市場調查報告書
商品編碼
1466483
生物保存市場:按產品、生物樣本、應用和最終用戶 - 全球預測 2024-2030Biopreservation Market by Product (Biopreservation Media, Equipment, Lab Information Management Systems), Biospecimens (Cells, Microorganisms, Organs), Application, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年生物防腐市場規模為87億美元,預計2024年將達98.9億美元,2030年將達214.9億美元,複合年成長率為13.79%。
生物保存是一種透過在低溫下穩定其代謝活性來保存細胞、組織和器官等生物材料的過程。它在醫學、農業、生物多樣性保護等各個領域中發揮著重要作用。生物保存的重要性在於其能夠長期維持生物樣本的功能和完整性,從而促進研究工作、改善再生醫學的臨床結果並保護遺傳資源。然而,建立和維護專門的生物保存設施成本高昂,阻礙了小型最終用戶設施的快速實施。此外,處理敏感生物材料需要訓練有素的人員,這進一步增加了這些資源管理的複雜性。市場相關人員正在努力透過推動冷凍保存、玻璃化和低溫保存來實施具有成本效益的生物保存方法。毒性降低的新型冷凍保護劑(CPA)的開發顯著提高了保存過程的效率。持續的進步旨在克服固有的限制並提高保護方法的效率,以確保研究、臨床應用和生物多樣性保育工作取得最佳結果。
主要市場統計 | |
---|---|
基準年[2023] | 87億美元 |
預測年份 [2024] | 98.9億美元 |
預測年份 [2030] | 214.9億美元 |
複合年成長率(%) | 13.79% |
擴大採用冷凍作為生物保存的首選技術
冷凍保存是一種生物保存技術,涉及在極低的溫度下冷凍生物樣品,例如細胞、組織或整個生物體。這種方法通常用於保存精子、卵子、胚胎和其他細胞以進行研究。化學保存使用化學物質來阻止生物樣本劣化或變質。此方法廣泛應用於組織學、病理學和電子顯微鏡中製備用於顯微鏡檢查的組織樣本。
推出新型生物儲存設備,提升產品功能與可靠性
生物保存介質的配製可提高細胞、組織和器官等生物樣本的活力和穩定性。這些介質含有冷凍保護劑和抗氧化劑等多種成分,可保護生物檢體在冷凍、解凍和儲存過程中免受損壞。生物保存設備包括用於保存生物標本的各種專用設備和儀器。包括超低溫冷凍櫃、反應器、樣本儲存系統、培養箱等。 LIMS 在維護樣品可追溯性和確保資料完整性方面發揮關鍵作用。 LIMS 幫助研究人員和實驗室人員有效編目、追蹤和檢索樣本。
增強生物樣本保存功能,保護細胞和組織訊息
微生物(包括細菌、真菌和病毒)的生物保存需要冷凍或冷凍乾燥以保持研究應用的活力。從各種來源(包括人類、動物和植物組織)收穫的細胞可以儲存用於研究、移植和治療。保存心臟、腎臟和肝臟等整個器官對於移植至關重要。器官的生物保存包括冷凍保存和灌注技術,以延長移植前的壽命。
應用:臨床試驗期間生物保存活動的潛力
生物銀行儲存生物樣本用於研究、診斷和未來研究。臨床試驗保持生物樣本的完整性以獲得準確的測試結果,藥物發現保留細胞株和組織以篩檢潛在的候選藥物。再生醫學涉及保存幹細胞和組織以進行移植和再生治療。治療藥物需要生物保存,以確保生物藥品在儲存和運輸過程中的穩定性。
最終用戶:全球基因庫生物保存活動的新需求
生物保存服務於各種最終用戶,包括儲存用於研究的遺傳物質的基因庫。生物樣本庫用於儲存用於研究活動的醫學樣本。醫院透過保存用於移植的組織和器官來幫助治療患者。
區域洞察
再生醫學的進步、生命科學研究投資的增加以及個人化醫療意識的不斷增強正在推動美洲(尤其是北美)的生物保存產業的發展。由於強大的醫療基礎設施和主要市場參與者的存在,美國和加拿大的市場正在成長。由於製藥業的蓬勃發展和政府對生物研究活動的支持不斷增加,亞洲生物保存市場正在迅速擴大。中國、印度、韓國和日本等國家正大力投資幹細胞研究和開發,增加了對生物保存解決方案的需求。歐洲生物保存市場主要受到生命科學研究和發展以及個人化醫療計劃資金增加的推動。歐盟(EU)大力投資創新藥物計畫(IMI)等計劃,旨在加速開發更安全、更有效的治療方法。生物樣本庫在歐洲也被廣泛應用,許多國家都建立了國家生物樣本庫。
FPNV定位矩陣
FPNV定位矩陣對於評估生物保存市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對生物保存市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.生物防腐市場的市場規模與預測是多少?
2.生物保存市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些?
3.生物保存市場的技術趨勢和法規結構是什麼?
4.生物防腐市場主要廠商的市場佔有率是多少?
5. 進入生物防腐市場的適當型態和策略手段是什麼?
[192 Pages Report] The Biopreservation Market size was estimated at USD 8.70 billion in 2023 and expected to reach USD 9.89 billion in 2024, at a CAGR 13.79% to reach USD 21.49 billion by 2030.
Biopreservation is the process of preserving biological materials, such as cells, tissues, and organs, by stabilizing their metabolic activity at reduced temperatures. It plays a crucial role in various fields like medicine, agriculture, and biodiversity conservation. The significance of biopreservation lies in its ability to maintain the function and integrity of biological samples for extended periods, thereby facilitating research efforts, improving clinical outcomes in regenerative medicine, and conserving genetic resources. However, establishing and maintaining specialized facilities for biopreservation can be expensive, impeding their fast adoption in small-scale end-user facilities. Moreover, the need for trained personnel to handle sensitive biological materials adds an additional layer of complexity to managing these resources. Market players are working on introducing cost-effective biopreservation methods by advancing cryopreservation, vitrification, and hypothermic storage. The development of new cryoprotective agents (CPAs) with reduced toxicity has significantly improved the efficiency of preservation processes. Ongoing advancements are aimed at overcoming inherent limitations and enhancing the efficiency of preservation methods to ensure optimal outcomes in research, clinical applications, and biodiversity conservation efforts.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 8.70 billion |
Estimated Year [2024] | USD 9.89 billion |
Forecast Year [2030] | USD 21.49 billion |
CAGR (%) | 13.79% |
Type: Increasing adoption of cryopreservation as a preferred technique of biopreservation
Cryopreservation is a biopreservation technique that involves freezing biological samples, such as cells, tissues, or even whole organisms, at extremely low temperatures. This method is commonly used in the preservation of sperm, eggs, embryos, and other cells for research. Chemical preservation relies on the use of chemicals to arrest the degradation and decay of biological samples. This method is widely applied in histology, pathology, and electron microscopy to prepare tissue samples for examination under a microscope.
Product: Introduction of new biopreservation equipment with improved features and reliability
Biopreservation media are formulated to extend the viability and stability of biological samples, such as cells, tissues, and organs. These media contain a variety of components, including cryoprotectants and antioxidants, which protect biological material from damage during freezing, thawing, or storage. Biopreservation equipment includes a range of specialized devices and instruments used in the preservation of biological samples. It includes cryogenic freezers, bioreactors, sample storage systems, and incubators. LIMS plays an important role in maintaining sample traceability and ensuring data integrity. It helps researchers and lab personnel efficiently catalog, track, and retrieve samples.
Biospecimen: Enhanced capabilities of biopreservation to protect cell and tissue matters
Biopreservation of microorganisms, including bacteria, fungi, and viruses, involved freezing or lyophilization to maintain their viability for research applications. Cells from various sources, such as human, animal, and plant tissues, can be preserved for research, transplantation, or therapeutic use. Preserving whole organs, such as hearts, kidneys, or livers, is crucial for transplantation. Organ biopreservation includes cold storage or perfusion techniques to extend their life until they can be transplanted.
Application: Potential use of biopreservation activities during clinical trials
Biobanking involves preserving biological samples for research, diagnostics, and future studies. Clinical trials maintain the integrity of biological specimens for accurate trial results, while drug discovery includes storing cell lines and tissues for screening potential drug candidates. Regenerative medicine includes preserving stem cells and tissues for transplantation and regenerative therapies. In therapeutics, biopreservation is necessary to ensure the stability of biopharmaceuticals during storage and transport.
End-User: Emerging need for biopreservation activities among gene banks worldwide
Biopreservation serves various end-users, including gene banks, which store genetic material for research. Biobanks use it to preserve medical samples for research activities. Hospitals benefit from preserving tissues and organs for transplantation, aiding patient care.
Regional Insights
In the Americas, particularly in North America, the biopreservation industry is driven by advancements in regenerative medicine, increased investments in life sciences research, and growing awareness regarding personalized medicine. The United States and Canada observe a growing market owing to its strong healthcare infrastructure and the presence of major market players. Asia's biopreservation market is rapidly expanding due to its booming pharmaceutical industry and increasing government support towards biological research activities. Nations such as China, India, South Korea, and Japan are witnessing growing demands for biopreservation solutions as they invest heavily in stem cell research & therapy development. Europe's biopreservation market is primarily driven by a strong focus on research & development in the life sciences sector and increasing funding for personalized medicine initiatives. The European Union (EU) has been investing significantly in projects such as the Innovative Medicines Initiative (IMI) aimed at accelerating the development of safer and more effective treatments. Biobanking is also widely practiced across Europe, with many countries having established national biobanks.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Biopreservation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biopreservation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Biopreservation Market, highlighting leading vendors and their innovative profiles. These include Audubon Bioscience, Azenta Life Sciences, Bio-Techne Corporation, BioIVT LLC, BioLife Solutions Inc., Charles River Laboratories International, Inc., Chart Industries, Inc., Eppendorf SE, Exact Sciences Corporation, Helmer Scientific Inc., LANXESS Corporation, Lifeline Scientific Inc., Merck KGaA, MVE Biological Solutions, OPS Diagnostics, LLC, Princeton CryoTech Inc., REPROCELL Inc., Sierra Molecular Corporation, So-Low Environmental Equipment Co., STEMCELL Technologies Inc., Taylor-Wharton, Thermo Fisher Scientific Inc., ThermoGenesis Holdings, Inc., Upkara, and X-Therma Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Biopreservation Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biopreservation Market?
3. What are the technology trends and regulatory frameworks in the Biopreservation Market?
4. What is the market share of the leading vendors in the Biopreservation Market?
5. Which modes and strategic moves are suitable for entering the Biopreservation Market?